Indications and Results of Telecobalt Therapy in Epithelial Tumors of the Oral Cavity

Author:

Banfi Alberto1,Milani Franco1

Affiliation:

1. Istituto di Radiohgia dell'Università e Divisione Radiologica dell'Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano

Abstract

A report of the results obtained in 194 cases of epithelial tumors of the oral cavity subjected to telecobalt therapy between June 1958 and December 1964 at the Institute of Radiology, University of Milan, and the Radiology Division of the National Cancer Institute. The criteria for establishing whether the treatment was indicated and the principles of selection of cases are specified. In the majority of cases the tumors were no longer circumscribed (T3-T4) and in over half the cases regional lymph node metastases were present when treatment commenced. Thirty-six patients had previously been subjected to radiotherapy or surgery. Telecobalt therapy was given almost exclusively to stationary fields using one or two portals of entry. Tumors of the floor of the mouth were often irradiated through wedges of lead. In 80% of the cases a tumor-dose of between 5000 and 6000 r was given over 6–8 weeks. At the end of treatment the tumor had completely disappeared in 22.7% of the patients, regressed to some extent in 40.6% and was unchanged or had deteriorated in 36.7%. The survival curves show that 2/3 of the patients died within two years of starting treatment; the five-year survival rate was 10.9%. This case-series confirmed that the prognosis is poorer in cases with regional lymph node metastases at the start of treatment and in patients subjected to telecobalt therapy for relapse after radiotherapy or surgery. The results obtained with telecobalt therapy proved to be considerably inferior to those obtained with curietherapy and so the latter is recommended in cancers of the oral cavity whenever it is feasible. Telecobalt therapy may be indicated, mainly as a symptomatic palliative, in very extensive infiltrating tumors adhering to the bone structures and in patients with inoperable lymph node metastases.

Publisher

SAGE Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3